🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Thanks to rapid reendothelialization derived from the pro-healing property ...
Status
Terminated
Location
Yonsei university Wonju College of Medicine
Start Date
2011-10
Trial ID
NCT01394848
XIENCE V USA is a prospective, multi-center, multi-cohort postapproval stud...
Status
Completed
Location
Birmingham Heart Clinic, PC
Start Date
2009-08
Trial ID
NCT01106534
The purpose of this study is to evaluate the safety and effectiveness of th...
Status
Completed
Location
Scripps Clinic
Start Date
2009-02
Trial ID
NCT01500434
Treatments Being Tested
A prospective, randomized, multicenter study in patients with an indication...
Status
Unknown
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02303717
Treatments Being Tested
The purpose of this study is to evaluate the safety of reducing dual antipl...
Status
Unknown
Location
Kyoto University Graduate School of Medicine
Start Date
2018-04-02
Trial ID
NCT03462498
Treatments Being Tested
The DAPT Study is a double blind randomized controlled trial intended to de...
Status
Completed
Location
Thomas Hospital
Start Date
2009-10
Trial ID
NCT00977938
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of th...
Status
Completed
Location
Baptist Medical Center Princeton
Start Date
2009-01
Trial ID
NCT00823212
Treatments Being Tested
The purpose of this study is to evaluate the safety and effectiveness of th...
Status
Completed
Location
Medical Center of the Rockies (Loveland)
Start Date
2009-10
Trial ID
NCT01510327
Treatments Being Tested
Factorial 2x2, all-comer, multicentre, randomized controlled trial (ratio 1...
Status
Active Not Recruiting
Location
IMELDA
Start Date
2023-10-13
Trial ID
NCT05952206
The aim of the study is to evaluate the efficacy and safety of sirolimus-el...
Status
Completed
Location
State Research Institute of CIrculation Pathology
Start Date
2015-03
Trial ID
NCT02681016
Treatments Being Tested